Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
In patients with advanced IDH1-mutated relapsed or refractory AML, ivosidenib at a dose of 500 mg daily was associated with a low frequency of grade 3 or higher treatment-relate...